Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Berenberg Bank bearish on Atlassian (NASDAQ: TEAM) despite its stable performance in Q3 FY23

Analysts remain Neutral on Atlassian despite the software company reporting revenue growth in the first quarter of fiscal 2023. Of the 27 analysts who cover the stock, majority have recommended holding it.

Akanksha Vashisht | 03 July 2023

Brokers suggest buying these two tech stocks despite a reported drop in their revenues

TD SYNNEX (NYSE: SNX) and Transphorm Inc. (NASDAQ: TGAN) released their financial results on June 27, 2023. Both the companies belong to the technology sector, with TD SYNNEX engaged in the cloud and cybersecurity arena and Transphorm being a semiconductor designer and manufacturer.

Akanksha Vashisht | 29 June 2023

Vertex Energy (NASDAQ: VTNR) sees rating upgrade from brokers as it reports first commercial renewable diesel sale

Vertex Energy saw its share price moving higher as it completed the first series of renewable diesel commercial transactions. The produce came from the company’s Alabama refinery.

Akanksha Vashisht | 28 June 2023

Brokers raise target price on Darden Restaurants (NYSE: DRI) post Q4FY23 announcement

Darden Restaurants (NYSE: DRI)is a restaurant chain operator in the US, with a market capitalization of around US$ 20 billion. It is the parent company of some of the largest US full-service operators including Olive Garden, Cheddar’s Scratch Kitchen, and The Capital Grille among …

Akanksha Vashisht | 26 June 2023

Analysts upgrade Oracle Corporation (NYSE: ORCL) to ‘Buy’ post Q4FY23 announcement

Oracle Corporation, a database technology and software provider, received rating upgrade from analysts following the release of its financial results for Q4 FY23. Piper Sandler Companies and Keybanc Capital upgraded their ratings on Oracle Corporation to ‘Buy’ soon after the company released its earnings …

Akanksha Vashisht | 22 June 2023

Analysts maintain ‘Buy’ rating on Catalyst Pharmaceuticals (NASDAQ: CPRX) following partnership announcement with Santhera

Catalyst Pharmaceuticals remained on the ‘Buy’ list of analysts after it announced ia partnership with Santhera Pharmaceuticals Holding. Analysts have given a mean recommendation rating of 2.2 on CPRX post the announcement.

Akanksha Vashisht | 21 June 2023

Enovix Corp. (NASDAQ: ENVX) achieves Q2 production forecast ahead of schedule; analysts retain Buy rating

Enovix Corp (NASDAQ: ENVX), a producer of silicon-anode lithium-ion batteries, recently announced the completion of its Q2 2023 forecast of 18,000 units produced in its Fab1 site in Freemont. The target was achieved with over two weeks left in the quarter. Thus, the company …

Akanksha Vashisht | 20 June 2023

Brokers give thumbs up to ChargePoint Holdings' (NYSE: CHPT) Q1FY24 earnings, retain Buy rating

ChargePoint Holdings (NYSE: CHPT) released its results for the first fiscal quarter ended April 30, 2023, on June 02, 2023. The company reported a revenue of US$ 130 million, which was 59% higher than the company’s revenue in the same quarter of the previous …

Akanksha Vashisht | 16 June 2023

Analysts retain ‘Buy’ rating on Academy Sports and Outdoors Inc despite profit drop in Q1FY2023

Analysts maintained their ‘Buy’ rating on Academy Sports and Outdoors Inc. (NASDAQ: ASO) despite the company reporting a drop in earnings for Q1 2023.

Akanksha Vashisht | 15 June 2023

Are analysts bullish on these tech stocks following Q1FY24 earnings announcement?

Technology stocks have had an interesting run during this year, with artificial intelligence (AI) taking center stage. Many tech stocks have benefited from the disruption caused by AI, making these stocks a good watch during this earnings season.

Akanksha Vashisht | 13 June 2023